Is PFS still a relevant endpoint for first-line TKIs?

Date 11 April 2018
Event ELCC 2018 European Lung Cancer Congress
Session First line for oncogene addicted lung cancer
Topics Non-Small-Cell Lung Cancer, Locally Advanced
Cancer Immunology and Immunotherapy
Lung and other Thoracic Tumours
Presenter Suresh Ramalingam
Authors S.S. Ramalingam
  • Emory University Winship Cancer Institute, 30322 - Atlanta/US